Thyme Care, a value-based cancer care navigation company, has rolled out a cancer survivorship program called Next Chapter Care that offers a personalized, longitudinal approach to cancer survivorship support. That is a program that offers coordinated oncology support after the end of active treatment to the over 15,000 members of Thyme Care who have finished cancer treatment.
The number of cancer survivors in the U.S. is increasing and is now over 18 million, with projections that this number will surpass 22 million by 2035.
However, some cancer survivors may have a medical or psychological need after the end of cancer treatment. Faced with long-term side effects, behavioral health challenges, and hormone therapies, many survivors are left to manage these healthcare challenges on their own.
Instead of patient survivorship being a standalone element of care, the program continues the relationship between Thyme Care and members throughout diagnosis, treatment, and recovery, the company says. Last year, Asma Dilawari, a board-certified medical oncologist, joined Thyme Care as its medical director of oncology care to spearhead the growth of the survivorship program.
There’s a gap that I saw when I was in clinic at some point after their initial cancer treatment, whether it’s chemotherapy, radiotherapy or immunotherapy, I don’t know, they’re not really the same anymore. They’ve got the long-term effects of all the treatments they’ve had, and I don’t think we’re seeing them anywhere near as much after that. And then send them on their way,” Dilawari told Fierce Healthcare. They weren’t the same issues when they were undergoing chemotherapy, of course, but they were still issues that were bothersome and some of them were issues such as weight gain, which would affect their level of physical activity, and they were tired all the time, they still had some side effects, such as neuropathy, which would impact on how they could do things day to day, and those are the things that are hard to address in a follow-up visit.
The survivorship program provides special nurse practitioner visits that specialize in medication management, emotional and mental health, cancer monitoring for future health needs, symptom management, and lifestyle targets.
The firm has established the essential elements of a survivorship care plan and a treatment summary, provider visits and long-term follow-up, among other factors, into it, and has integrated it into Thyme Care’s model. Instead of a one-time visit, the program will provide “long-term” follow-up with a care team, Dilawari said.
“When I first came to the Thyme Care world, I felt this was a great opportunity for us as a virtual care organization and organization with such a great reach across the country to provide a more long-term relationship,” she said. Before joining Thyme Care, Dilawari served as a Clinical Reviewer at the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER). She worked in the past at MedStar and Georgetown/Lombardi Comprehensive Cancer Center, where she had specialties in breast cancer.
Thyme Care has improved its content library and learning offerings to provide members with even more resources and information to help them be more active in their post-treatment care.
The program also provides wellness education, lifestyle modification support, emotional support, screening and diagnostic support, and connection to peer support groups. As a part of the program, cancer survivors also receive ongoing follow-up and flexible engagement services, such as phone-based services and self-directed educational resources that are available via Thyme Care Connect.
The company developed an embedded oncology system that streamlines the oncology system. It combines 24/7 specialized cancer care navigation services, technology and data insights, and oncologist-led therapeutic interventions. The company’s tech-enabled care team is integrated with over 1,400 oncologists as part of its hybrid collaborative care model, called Thyme Care Oncology Partners.
Thyme Care has seen a very prosperous scaling up of its business. By the end of 2024, it was treating 10,000 patients, and that has since risen to 100,000 actively treated cancer patients as of May 2026.
Next Chapter Care is provided within Thyme Care’s multidisciplinary oncology care model, which features oncology-trained doctors, nurses, licensed clinical social workers, and care navigators. This program builds on Thyme Care’s Oncology Nursing Certification Corporation (ONCC) credentialed nursing staff to provide organized survivorship care as an extension of the longitudinal oncology care continuum.
Thyme Care provides care to members throughout all 50 states through care teams in conjunction with over 1,400 oncologists and partners with national and regional health plans.
Thyme Care has announced an expansion of its cancer survivorship program, reinforcing its commitment to supporting patients long after active treatment ends. The enhanced initiative is designed to help cancer survivors navigate the physical, emotional, and practical challenges that often continue for years following diagnosis and treatment.
By extending its survivorship services, Thyme Care aims to address the growing need for coordinated, long-term care that helps patients maintain their quality of life and reduce the risk of complications after treatment.
Why Long-Term Survivorship Care Matters
Cancer survivors frequently face ongoing health concerns, including treatment side effects, mental health challenges, medication management, and follow-up screenings. Through its expanded program, Thyme Care provides personalized guidance, care coordination, and educational resources to ensure survivors receive continuous support throughout their recovery journey.
The company recognizes that survivorship is a lifelong process, and Thyme Care is working to bridge gaps in care that can emerge once intensive treatment concludes.
